Ayal Aizer, MD, MHS, says Alliance A071801 supports fractionated SRS as standard after resection, with comparable radiation necrosis rates. In an interview with CancerNetwork®, Ayal Aizer, MD, MHS, ...
The 10-year results from the phase 3 CHN HYPOPMRT trial (NCT00793962) showed that hypofractionated postmastectomy radiotherapy (PMRT) delivered over 3 weeks maintained durable locoregional control ...
Treatment options for patients with relapsed/refractory follicular lymphoma have expanded rapidly. CD19-directed CAR T-cell therapies are approved in the third-line setting and beyond, and CD20 x CD3 ...
The FDA cleared the SpaceOAR Flex System, a hydrogel spacer used during prostate cancer radiotherapy, in a 510 (k) supported by the HYDROSPACE trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results